EBITDA: Income before interest, taxes, depreciation and amortization.
Zura Bio Limited (ZURA) had EBITDA of $-25.48M for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
-- |
|
$-24.22M |
|
-- |
|
-- |
|
$25.50M |
|
$-25.50M |
|
$1.28M |
|
$-24.22M |
|
$-24.22M |
|
$-24.22M |
|
$-24.22M |
|
$-24.22M |
|
$-24.22M |
|
$-25.50M |
|
|
EBITDA |
$-25.48M |
112.22M |
|
112.22M |
|
$-0.22 |
|
$-0.22 |
|
| Balance Sheet Financials | |
$227.00M |
|
$0.12M |
|
$1.64M |
|
$228.64M |
|
$11.74M |
|
-- |
|
-- |
|
$11.74M |
|
$216.90M |
|
$216.90M |
|
$216.90M |
|
94.88M |
|
| Cash Flow Statement Financials | |
$-18.92M |
|
$-0.01M |
|
$135.12M |
|
$109.41M |
|
$225.59M |
|
$116.19M |
|
$5.01M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
19.33 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-18.94M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-11.17% |
|
-11.17% |
|
-10.59% |
|
-11.17% |
|
$2.29 |
|
$-0.17 |
|
$-0.17 |
|